{"name":"Bioverativ, a Sanofi company","slug":"bioverativ-a-sanofi-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BIVV009","genericName":"BIVV009","slug":"bivv009","indication":"Hemophilia A with inhibitors","status":"phase_3"}]}],"pipeline":[{"name":"BIVV009","genericName":"BIVV009","slug":"bivv009","phase":"phase_3","mechanism":"BIVV009 is a monoclonal antibody that inhibits tissue factor pathway inhibitor (TFPI) to enhance thrombin generation and restore hemostasis in hemophilia patients.","indications":["Hemophilia A with inhibitors","Hemophilia B with inhibitors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPV0tHX1M1ZVlNb0hhOExBQjhXNlQ1YXAxR25DNzY3eEJMMzlTckVBOE1iU3l3QklvZ3I3OU5tN25CVzA0WmRxeDRTSUlRNmFlaWphVm5lSmZEWDRGZ1VkVHAydGNPeGVWN0ZORk9wamdUY3hVSUMtcndJeU5xaXBVbktoR0RTLVEwTTdnTzlydmRhWms?oc=5","date":"2022-02-07","type":"regulatory","source":"BioPharma Dive","summary":"Sanofi’s Bioverativ deal begins to pay dividends with first new drug approval - BioPharma Dive","headline":"Sanofi’s Bioverativ deal begins to pay dividends with first new drug approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOLUdiQV9ETUR6RjNmeWJhbDVVTDMtc3poUWxrYktQdHZoX0Z6WGdQSDFxeFY1YkpRZWdvTHNGbERkWXNnMTFUZGYyNVFMTWRpczZobk1ITEdseDkzcElRdFROTG5PeHBlLTIwUmNNeTBBTFZWWmszTlZ6QUxQb1BxMWhoT29WeXpiV3cwOHlMUW9KQ2xiNFpBUlJCNUNfaC1EMzZ0cWRUcUZibk9l?oc=5","date":"2021-03-19","type":"pipeline","source":"Fierce Pharma","summary":"Sanofi parts ways with Oxford BioMedica on hemophilia tie-up inked by Bioverativ - Fierce Pharma","headline":"Sanofi parts ways with Oxford BioMedica on hemophilia tie-up inked by Bioverativ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPV0hIYVVWWU5rWFNYYmlaTkJEOUotSWswM2FyblZuX0RyY3FVX1hIc1MtdjZqa0dzOXFJTDJ0Ul9YdlNxNnFOSkJSQVh3U2ljdkJxSTNUaHd4dmd5SllQZ201M0JXanhDUVR3MC1jUnVoY2NGRmpvR3RXY09WMkxEQWljV0RoeDd1YjBRd1JIZldMVHJRbEFWeVc4cGJWZDdoY3hN?oc=5","date":"2019-07-29","type":"pipeline","source":"BioPharma Dive","summary":"Sanofi writes down hemophilia drug as competitive pressures rise - BioPharma Dive","headline":"Sanofi writes down hemophilia drug as competitive pressures rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZXBqeThjSWE5Z19VQmxxWWlxNktnbTRNUnpWejRraEVZQVZsY0RISTF5OXZWbUVjUUN0T2kyWmFfTzlKNUJMNVBNTF8wYS1kVDNBc3dES0k5YndVbU5jVDF2UzNQdmxMcWJIZktBbmhOWG1jSzFsMmZQQUYtbEVEMWVPSkw2TzBUTkxobHVzdk5LRnlMWW1wZWlqWXk1Z3plLURldVhDcEU2c0pURFBXNW1zQnNmeGcz?oc=5","date":"2019-06-14","type":"pipeline","source":"Fierce Pharma","summary":"Sanofi EVP's Bioverativ blabbing ends in insider trading cases - Fierce Pharma","headline":"Sanofi EVP's Bioverativ blabbing ends in insider trading cases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNSWVyUUFmWlhQSVZsZGpydGgwVDN6bFNNaU40U2ExcmlCRE5kc3JfNXNkWm5ObDJ3UU8xZnI2ZGRGMFRPbmg1WDJhZ1pyODZnbjZVSXk3a2t0LXhMN280TklJa2UzMUVzQ3ZYc1ZTMktyRXlHZE1fcl9Xc2hQTWV5QmJrOWNuWkNfSndENHRDWEU4OWIxUUdvb2FLdWM5cW5VajZIZ25XVHRJWW1r?oc=5","date":"2019-04-26","type":"deal","source":"Fierce Pharma","summary":"Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch - Fierce Pharma","headline":"Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPQU5hWDMyZXhoN2JVRVNPb0lEbW4wNGRPN1dTZWVBY3Z3SkllQzQ1T3FMLVBYMTN5TlZKU2VyeEhUMEp4b3BKUnlLa2ZPZ3BXNzJuLWgxa2dSMG9fRWJkZkhaWTlXbEEzZDFaa1FqQ0pkQ0tmZm0zajR4bWJFNWhSd2NlVUtfZw?oc=5","date":"2018-02-01","type":"pipeline","source":"Chemistry World","summary":"Sanofi enters M&A bonanza - Chemistry World","headline":"Sanofi enters M&A bonanza","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPeWVlR3ZTT1hnQWRFcUtaN3RqMUNxX0JzV3RjYlpGUVJTclhWcWhKN0prVXFPVlJMcG5CTVRsWWdUZ05CM3MyZzk1aGxJSVV5ZUI4bXFFWnJ0UjJ6bGV1TjVqZFpscWJwV1NqdlNLX1I5c0VRcmZTdHlqSFZxTnQ2U3lRM0xwU3VQSDlCRS1WcTUyaDd3VUE?oc=5","date":"2018-01-22","type":"deal","source":"Fierce Pharma","summary":"Sanofi snaps up Biogen's spun-out Bioverativ in $11.6B deal - Fierce Pharma","headline":"Sanofi snaps up Biogen's spun-out Bioverativ in $11.6B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUjZxTjIzX3BMYzc1cGR0eU5SSUdJZnBubnFHZ3lyeEVHSHNzTjI3M3FvRHFPdkl5TjEzc2EzZFZQQkVqQ3lqSE9YX3Bac0thcDJiTF9meFZ1Njdwdm1fWnVKSmFDMElYbDFXQnVPdWo4N2lFa1B6YUNxX3Q1QmhCY0pPaFl5Ti1qTHVKNGtn?oc=5","date":"2018-01-22","type":"deal","source":"Pharmaceutical Technology","summary":"Sanofi acquires Bioverativ for $11.6bn - Pharmaceutical Technology","headline":"Sanofi acquires Bioverativ for $11.6bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOb09VdkMyUUU4NkUwdE40Z2tPSGpwMG90OFE2VUFTaXVDWEdERjdESVVSdWhLdU5IczdxQ2V3ZElKREVycFVTM0ZwcGVMZ0pPVjEwalhLeFpDRzhyU1NLZVltbVdwRC10Zk05dnRxaFhUQktlN3JnR1NmdC1aVi10SER5d0hXaWIwNHVsRE40YUg5a1cyV1E?oc=5","date":"2018-01-22","type":"deal","source":"BioPharma Dive","summary":"Sanofi beefs up pipeline with $11B Bioverativ buy - BioPharma Dive","headline":"Sanofi beefs up pipeline with $11B Bioverativ buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbElFTG55djZJWXdoSjRfTjJfNFNsaUdvTzZxOU5kR05LZ0FBbThaSEdCSXJVRGRSMWQ5UXpEV3VnMU8wSVR2dzFYUzZjUUQzUTJkVXQtWjQ3VWFqbDlHeHVuZFNRZFV4MjU3VTg0eXppbFpYM3NtdDhyX05Td1k2dkdFQVlFTjhadWRuS0NhSFBFT1A4M1J1ZUJlYzdPU0FuRUkweXp6a3BCUHY2V1oySm5kMi0xdzNwSkhBWGFUdUk?oc=5","date":"2018-01-22","type":"deal","source":"WSJ","summary":"Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion - WSJ","headline":"Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPMUpxSTJDQVFkdDU3bWxobWhTdVpFaWlyRWI4OFRZeHY0cExSOVVxOWJWRFdNZzB4MXU3Uzdhd0NxRE1SZVNmZUFrNkY2WUpLc2M1Y2IzMUZkT0xSaEFxTEZoclZyU0VtZlBHVmdOOG5NNTAyUkhaQWUzN3pXaHEzRFVaR2d4MXRVZVl4RXE0OA?oc=5","date":"2018-01-22","type":"deal","source":"The New York Times","summary":"Sanofi, Facing Threat From Generics, Moves to Buy Hemophilia Drug Maker (Published 2018) - The New York Times","headline":"Sanofi, Facing Threat From Generics, Moves to Buy Hemophilia Drug Maker (Published 2018)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdnV0NHdUT3N2ZWl1b0RSU0N2Zm9uNFV3MjFabGhQWDFiUmMwVVdIc1RvM0xWUlBUOFgyY0Jjc3owQVFEZG1icUFrWU9hemZQekx4NWJrUGx5ZEF3c1NFaFRzdk4tQkJKT1luX0RzOTMxa0RpOURkZnhWUG1UekRsZEpuRG52TnA2RTdlQTBkSlVBZ0NmVW44MnFNOTRub0MyZWdWVlJROHZIeXZObF9HZ0JUVTNoUVRsakQxRFRwU21FcTVJRmQxdXhB?oc=5","date":"2018-01-22","type":"pipeline","source":"The Boston Globe","summary":"Sanofi expands footprint in Mass. with $11.6 billion purchase of Waltham-based Bioverativ - The Boston Globe","headline":"Sanofi expands footprint in Mass. with $11.6 billion purchase of Waltham-based Bioverativ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}